Prostate Cancer Screening and the Goldilocks Principle: How Much Is Just Right?
作者信息
Faiena Izak, Holden Stuart, Cooperberg Mathew R, Holden Stuart, Soule Howard R, Simons Jonathan W, Morgan Todd M, Penson David F, Morgans Alicia K, Hussain Maha
机构信息
Izak Faiena and Stuart Holden, David Geffen School of Medicine at UCLA, Los Angeles, CA; Mathew R. Cooperberg, University of California, San Francisco, San Francisco, CA; Stuart Holden, Howard R. Soule, and Jonathan W. Simons, Prostate Cancer Foundation, Santa Monica, CA; Todd M. Morgan, University of Michigan, Ann Arbor, MI; David F. Penson, Vanderbilt University Medical Center, Nashville, TN; and Alicia K. Morgans and Maha Hussain, Northwestern University, Chicago, IL.
出版信息
J Clin Oncol. 2018 Apr 1;36(10):937-941. doi: 10.1200/JCO.2017.76.4050. Epub 2018 Feb 5.
Abstract
摘要
相似文献
1
Prostate Cancer Screening and the Goldilocks Principle: How Much Is Just Right?前列腺癌筛查与“金发姑娘原则”：多少才刚刚好？
J Clin Oncol. 2018 Apr 1;36(10):937-941. doi: 10.1200/JCO.2017.76.4050. Epub 2018 Feb 5.
2
Doing it right: how, not whether, to perform prostate-specific antigen screening.正确做法：如何进行前列腺特异性抗原筛查，而非是否进行筛查。
Eur Urol. 2015 Sep;68(3):361-2. doi: 10.1016/j.eururo.2015.02.035. Epub 2015 Mar 18.
3
Controversy of the prostate-specific antigen test era: should prostate cancer be detected and treated in all patients?前列腺特异性抗原检测时代的争议：是否应对所有患者进行前列腺癌的检测和治疗？
Chin Med J (Engl). 2013;126(15):2803-4.
4
Summary statement on screening for prostate cancer in Europe.关于欧洲前列腺癌筛查的总结声明。
Int J Cancer. 2018 Feb 15;142(4):741-746. doi: 10.1002/ijc.31102. Epub 2017 Oct 25.
5
Prostate cancer: Personalized risk - stratified screening or abandoning it altogether?前列腺癌：个性化风险分层筛查还是完全放弃？
Nat Rev Clin Oncol. 2016 Mar;13(3):140-2. doi: 10.1038/nrclinonc.2016.11. Epub 2016 Feb 2.
6
PSA cancer screening: a case for shared decision-making.前列腺特异性抗原（PSA）癌症筛查：共同决策的一个实例
J Fam Pract. 2020 Jan/Feb;69(1):26;28;30;32;46.
7
Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States.健康素养对美国前列腺特异性抗原筛查中共同决策的影响。
Cancer. 2021 Jan 15;127(2):249-256. doi: 10.1002/cncr.33239. Epub 2020 Nov 9.
8
Prostate-specific antigen (hK3) and human prostatic glandular kallikrein (hK2) in the detection of early stage human prostate cancer.前列腺特异性抗原（hK3）和人前列腺腺激肽释放酶（hK2）在早期人类前列腺癌检测中的应用
J Lab Clin Med. 1998 Apr;131(4):298-9. doi: 10.1016/s0022-2143(98)90178-0.
9
Managing localized prostate cancer in the era of prostate-specific antigen screening.在前列腺特异性抗原筛查时代管理局限性前列腺癌。
Cancer. 2013 Nov 15;119(22):3906-9. doi: 10.1002/cncr.28301. Epub 2013 Sep 4.
10
Screening for Prostate Cancer: Recommendation Statement.前列腺癌筛查：推荐声明。
Am Fam Physician. 2018 Oct 15;98(8):Online.
引用本文的文献
1
Does Helping Others Always Benefit Health? Longitudinal Evidence on the Relationship between Helping Behavior and Depression: The Mediating Role of Life Satisfaction and the Moderating Effect of IADL.帮助他人总是有益于健康吗？关于帮助行为与抑郁之间关系的纵向证据：生活满意度的中介作用和工具性日常生活活动的调节作用
Depress Anxiety. 2024 Jul 25;2024:2304723. doi: 10.1155/2024/2304723. eCollection 2024.
2
Urothelial carcinoembryonic antigen 1 score for early detection of prostate cancer and risk prediction.尿路上皮癌胚抗原1评分用于前列腺癌的早期检测和风险预测。
Cancer Med. 2022 Aug;11(15):2875-2885. doi: 10.1002/cam4.4629. Epub 2022 Mar 15.
3
Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): an Evolving Treatment Paradigm.转移性激素敏感型前列腺癌（mHSPC）的管理：一个不断发展的治疗范例。
Curr Treat Options Oncol. 2019 Jul 9;20(9):69. doi: 10.1007/s11864-019-0668-8.
4
Testing of a Tool for Prostate Cancer Screening Discussions in Primary Care.基层医疗中前列腺癌筛查讨论工具的测试
Front Oncol. 2018 Jun 28;8:238. doi: 10.3389/fonc.2018.00238. eCollection 2018.
本文引用的文献
1
Impact of 2012 USPSTF Screening PSA Guideline Statement: Changes in Primary Care Provider Practice Patterns and Attitudes.2012年美国预防服务工作组前列腺特异性抗原筛查指南声明的影响：初级保健提供者实践模式和态度的变化
Urol Pract. 2017 Mar;4(2):126-131. doi: 10.1016/j.urpr.2016.04.003. Epub 2016 Oct 6.
2
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.调和欧洲随机前列腺癌筛查研究（ERSPC）和前列腺、肺癌、结直肠癌和卵巢癌筛查试验（PLCO）中筛查对前列腺癌死亡率的影响。
Ann Intern Med. 2017 Oct 3;167(7):449-455. doi: 10.7326/M16-2586. Epub 2017 Sep 5.
3
African-American Prostate Cancer Disparities.非裔美国人前列腺癌差异
Curr Urol Rep. 2017 Aug 14;18(10):81. doi: 10.1007/s11934-017-0724-5.
4
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.阿比特龙用于既往未接受过激素治疗的前列腺癌患者
N Engl J Med. 2017 Jul 27;377(4):338-351. doi: 10.1056/NEJMoa1702900. Epub 2017 Jun 3.
5
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.阿比特龙联合泼尼松治疗转移性去势敏感性前列腺癌。
N Engl J Med. 2017 Jul 27;377(4):352-360. doi: 10.1056/NEJMoa1704174. Epub 2017 Jun 4.
6
The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and Comment.美国预防服务工作组2017年关于前列腺癌筛查的建议声明草案：邀请审查与评论。
JAMA. 2017 May 16;317(19):1949-1950. doi: 10.1001/jama.2017.4413.
7
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.多参数 MRI 和 TRUS 活检在前列腺癌（PROMIS）中的诊断准确性：一项配对验证性研究。
Lancet. 2017 Feb 25;389(10071):815-822. doi: 10.1016/S0140-6736(16)32401-1. Epub 2017 Jan 20.
8
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.胚系 BRCA2 突变驱动具有不同进化轨迹的前列腺癌。
Nat Commun. 2017 Jan 9;8:13671. doi: 10.1038/ncomms13671.
9
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
10
Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States.美国前列腺癌诊断时远处转移的增加。
JAMA Oncol. 2017 May 1;3(5):705-707. doi: 10.1001/jamaoncol.2016.5465.
Zotero 插件